Looking for Kinetico Water Systems? Click Here!

Precision Medicine Practice Corporate Strategy and Development

Our Corporate Strategy and Development services apply our industry knowledge combined with a data driven approach to provide actionable direction to your strategic growth plan.

Service lines include:

Market Opportunity Assessment

Market Analysis

Competitor Analysis

Customer Buying Preferences

Target Market Prioritization

Voice of Customer Survey

Key Opinion Leader Interviews

Go-To-Market Strategy

Market Opportunity Assessment

Value Proposition Development

Market Entry Strategy

Commercial Deployment Modeling

Mergers and Acquisitions

Due Diligence

Technical and Commercial Evaluation

Opportunities for Improvement (OFI) Assessment

Partnering Support

Partner Identification / Prioritization

Secure and Facilitate Partnering Meetings

Manage Follow Up Process

Support Deal Negotiations

Click the Tabs Below for Corporate Strategy and Development Case Studies, White Papers and Articles, and Blog


Case Studies
  • Market Opportunity Assessment

    Situation: An innovative preclinical CRO with multiple disruptive service offerings retained Kineticos to conduct an evaluation of each of their


    Read this Case Study

  • 503B Compounding Pharmacy Market Assessment

    Situation: A global biopharma company was interested in a comprehensive evaluation of the 503B compounding pharmacy market. The client was


    Read this Case Study

  • Primary Research Study

    Kineticos conducted primary research via KOLs and an online survey to give our client qualitative and quantitative data to support


    Read this Case Study

  • Contract Development and Manufacturing Due Diligence

    Challenge: An international private equity firm was looking at acquiring a Contract Development and Manufacturing Organization and needed to understand


    Read this Case Study

  • Go-to-Market Strategy and Tactical Deployment Plan

    Situation: A privately held emerging biotech company, with an innovative cancer detection test, retained Kineticos to assist them in effectively


    Read this Case Study

  • Voice of Customer Study

    Situation: A joint venture between two European companies was looking to maximize the commercial potential of its automated plate reader


    Read this Case Study

  • Companion Diagnostics, Big Data, and New Approaches: How Does Neurosciences Catch Up to Oncology in Precision Medicine?

    In September, we turn our focus onto Precision Medicine and its impact on the life sciences. Kineticos held 3 conversations


    Read this Article

  • A Look Inside the Diagnostics Market

    The life science ecosystem is a complex organism being influenced by patients, providers, payers, and regulators in the precision medicine,


    Read this Article

  • Product Launch Metrics

    Written by Bill Finger, Executive Vice President & Managing Director, Kineticos With the culmination of a product created through open


    Read this Article

  • Staying the Course

    Written by Mark Osterman, Senior Vice President, Kineticos Kineticos recently announced Q4 2015 results of the Biopharma CEO Confidence Index,


    Read this Article

  • Central Laboratories Holy Grail: Six Keys to Achieving Preferred Provider Status with BioPharmaceutical Companies

    Article Preview A critical growth driver for most any central laboratory
 is its ability to gain preferred provider agreements (PPAs):


    Read this Article

  • How Metrics Can Help Identify and Solve Operational Challenges

    Article Preview As the sophistication of operational practices across life sciences increases; unfortunately, so do the difficulty and complexity of


    Read this Blog Post

  • Growth by Acquisition in Life Sciences: Do You Have a Plan?

    Article Preview As the life sciences landscape continually changes, growth by acquisition has become increasingly common. Recent deals, such as


    Read this Blog Post

  • Next Generation Sequencing: Using Technology to Develop Mutually-Beneficial Partnerships

    Article Preview Arup Laboratories announced it will begin offering next-generation sequencing (NGS) based high resolution Human Leukocyte Antigen (HLA) genotyping


    Read this Blog Post

  • Role of Companion Diagnostics in Immuno-oncology Race Unfolding

    Article Preview Important oncology events, including ASCO and ESMO, have recently displayed the fruits of the huge investment drug companies


    Read this Blog Post

  • Merck KGaA Announces Acquisition of Sigma-Aldrich, Increasing Lab Supply Division Growth

    Article Preview Germany’s Merck KGaA has announced the acquisition of Sigma-Aldrich Corporation, a global life sciences tools (LST) firm, based


    Read this Blog Post

  • Outsourcing as Opportunity

    Article Preview An article published in FiercePharma discussed the top 10 largest pharma layoffs in 2013. Whenever layoffs are announced


    Read this Blog Post

Subscribe to our internal think tank, Kineticos Research Institute